Macquarie Group
HRMY icon

Macquarie Group’s Harmony Biosciences HRMY Stock Holding History

Macquarie Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-127,275
Closed -$4.02M – 1642
2025
Q2 		$4.02M Sell
127,275
-150,243
-54% -$4.83M ﹤0.01% 1030
2025
Q1 		$9.21M Sell
277,518
-14,032
-5% -$503K 0.01% 827
2024
Q4 		$10M Sell
291,550
-1,197
-0.4% -$41.1K 0.01% 803
2024
Q3 		$11.7M Sell
292,747
-3,133
-1% -$110K 0.01% 800
2024
Q2 		$8.93M Sell
295,880
-4,026
-1% -$121K 0.01% 836
2024
Q1 		$10.1M Sell
299,906
-275,646
-48% -$8.85M 0.01% 823
2023
Q4 		$18.6M Sell
575,552
-376,841
-40% -$10.5M 0.02% 680
2023
Q3 		$31.2M Buy
952,393
+50,865
+6% +$1.77M 0.04% 545
2023
Q2 		$31.7M Buy
901,528
+72,859
+9% +$2.52M 0.04% 556
2023
Q1 		$27.1M Buy
828,669
+126,575
+18% +$5.76M 0.03% 595
2022
Q4 		$38.7M Buy
702,094
+41,250
+6% +$2.27M 0.05% 516
2022
Q3 		$29.3M Buy
660,844
+30,633
+5% +$1.49M 0.04% 584
2022
Q2 		$30.7M Buy
630,211
+224,843
+55% +$10.1M 0.03% 600
2022
Q1 		$19.7M Buy
+405,368
New +$16.5M 0.02% 765

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
VM
Valor Management Chicago, Illinois $86.2B AUM 12.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Macquarie Group's HRMY Position: Q3 2025 in Review

Macquarie Group sold out of Harmony Biosciences (HRMY) in Q3 2025, closing a stake of 127,275 shares — an estimated $4.02M sold.

Macquarie Group first reported a position in HRMY in Q1 2022 and held it in 14 quarters. The position peaked at $38.7M in Q4 2022. 296 funds tracked by Wall St. Rank hold HRMY as of Q3 2025.

  • Macquarie Group reported no remaining Harmony Biosciences position as of Q3 2025 after selling out during the quarter.
  • Macquarie Group sold 127,275 Harmony Biosciences shares in Q3 2025, an estimated $4.02M.
  • Macquarie Group first reported a position in Harmony Biosciences in Q1 2022 and held it in 14 quarters.
  • Macquarie Group's Harmony Biosciences position peaked at $38.7M in Q4 2022.
  • 296 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2025.

Based on Macquarie Group's 13F filing for Q3 2025, filed 13 Nov 2025.